Market Research Reports and Industry Reports

Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of the overall international pharmaceutical market. Utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.
The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs. Global injectable drug delivery market is expected to be worth $29b by 2015.

Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients.

The generic market with reference to innovative molecule (NCE) has become very competitive as several companies have already filed ANDAs for potential generic drugs in the near term. The study of the novel drug delivery companies and their formulation technologies will provide the potential value added opportunity in the generic field in terms of patients compliance or bioavailability enhancement. It will also provide an enhanced life cycle for drugs under patent coverage (life cycle extension).

This comprehensive report on novel drug delivery system focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies. This report enumerates the various formulation technologies involved in making value added formulations, pharmaceutical applications and advantages of specific technologies. Wherever possible, marketed drugs using a similar technology have been discussed as proof of validation along with the status of additional pipeline. The discussed proprietary formulation technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

This report will be helpful for those pharma companies who are exploring novel opportunities for their growth by in-licensing formulation technology or value added pipeline drugs available/being studied in the market.
N/A

List Of Tables

Figure 1
Refractory MDS/ RR AML: Emerging Therapeutics
UNMET NEED FOR AMLTable 2
Refractory MDS/ RR AML: Emerging Therapeutics
COMPETITIVE LANDSCAPE: RR/ HIGH-RISK MDS AND RR AML


List Of Figures

N/A

2016-2021 U.S. Hospital Infectious Disease Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities

This new report from VPGMarketResearch.com contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital

USD 6800View Report

2016-2021 U.K. Hospital Infectious Disease Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities

This new report from VPGMarketResearch.com contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital

USD 4450View Report

2016-2021 Spain Hospital Infectious Disease Testing Market: Supplier Shares, Sales Forecasts, Innovative Technologies, Competitive Strategies, Emerging Opportunities

This new report from VPGMarketResearch.com contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital

USD 4450View Report

Global Injectable Drug Delivery Sales Market Report 2016

Notes:Sales, means the sales volume of Injectable Drug DeliveryRevenue, means the sales value of Injectable Drug DeliveryThis report studies sales (consumption) of Injectable Drug Delivery in Global market, especially in

USD 4000View Report

United States Transdermal Drug Delivery Market Report 2016

Notes:Sales, means the sales volume of Transdermal Drug DeliveryRevenue, means the sales value of Transdermal Drug DeliveryThis report studies sales (consumption) of Transdermal Drug Delivery in United States market, focuses

USD 3800View Report

Europe Intranasal Drug Delivery Devices Market Report 2016

Notes:Sales, means the sales volume of Intranasal Drug Delivery DevicesRevenue, means the sales value of Intranasal Drug Delivery DevicesThis report studies sales (consumption) of Intranasal Drug Delivery Devices in Europe

USD 3900View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2500
  • Site Licence    $ 5000
  • Enterprisewide Licence    $ 7500
$ 2500

Reports Details

Published Date : Jun 2013
No. of Pages :123
Country :Global
Category :Healthcare
Publisher :MP Advisors
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment